On June 23, DexCom fell 5.04% in regular trading, trading at $68.78 USD/share, with Turnover of $163 million.
Within the Health Care Equipment sector where DexCom belongs, the overall sector is under broad pressure. Among individual stocks, Boston Scientific down 2.29%, Intuitive Surgical down 1.18%, Stryker down 0.94%, Abbott Laboratories down 0.22%, Medtronic PLC down 0.15%.
DexCom is a medical device company focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes management. Its product portfolio includes Dexcom G6, Dexcom G7, Dexcom Share, and Dexcom ONE.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments